Policy / Regulatory

Hubei Province Proposes National TCM Patent Medicine Procurement Alliance

CompanyDrug

Buchang Pharmaceuticals Gains NMPA Approval for BC008-1A Clinical Study

CompanyDrug

CDE Prioritizes Review of Pearl Bio’s Breatinib for NSCLC Treatment

CompanyDrug

Jiangsu Hengrui Medicine Gains NMPA Approval for HRS-6209 Clinical Study

CompanyDrug

I-Mab’s Lemzoparlimab Gains CDE Approval for HR-MDS Phase III Trial

CompanyDrug

Takeda’s Modakafusp Alfa and TAK-981 Gain NMPA Clinical Trial Approvals

CompanyDrug

Huahai Pharmaceutical Gains FDA Approval for Generic Fingolimod

CompanyDeals

Vathin Medical Instrument Raises Pre-Series B Funding Led by IDG Capital

CompanyPolicy / Regulatory

NMPA Issues Guidelines on Medical Device Grading Administration

Policy / Regulatory

Frontier Biotech’s FB2001 Inhalant Accepted for NMPA Review

CompanyDrug

Luye Pharma’s LY03015 Receives FDA Approval for Phase I Clinical Study

CompanyDeals

Hengrui Medicine to Incentivize Employees with Share Distribution